 Insider Purchases on May 5: Who Invested $10 Million in Their Own Business? I analyzed the latest insider trading data — and there are several very interesting signals. Top 3 trades of the day: Avalyn Pharma (AVLN) — Novo Holdings bought 555,555 shares at $18, investing $10 million. This is a +17% increase in their stake. The largest purchase of the day and the strongest signal of confidence from a major shareholder. Robostrategy (BOT) — two insiders at once: CEO Andrew Kai Kang ($2.46 million) and COO Marc Weinstein ($435k). A combined ~$2.9 million from management. Loews Corp (L) — director Dino Robusto opened a new position from scratch, buying $527k worth at $105.44. A new position from an insider is always worth attention. What else I noticed: • Clorox (CLX) — director Pierre Breber increased his stake by 38%, buying $429k worth. After the stock's decline, this is a strong signal. • Tenable (TENB) — CFO Matthew Brown bought 12,000 shares, increasing his stake by 65%. The CFO usually knows the finances best. • Willis Towers Watson (WTW) — CEO Carl Hess bought $510k worth at $255. Trend of the week: AI algorithms and biotech are the main market drivers. The FDA is actively integrating AI into drug approvals, and insiders are betting on fundamentally strong companies. Full analysis and trades — at asibiont.com Data: OpenInsider, AI agent analysis in 60 seconds